TEST:

MEBGEN™ BRAF 3 Kit

The MEBGEN™ BRAF 3 Kit was developed as a tumor-agnostic companion diagnostic for the detection of BRAF (v-raf murine sarcoma viral oncogene homolog B1) gene mutations (V600E). Clinical performance studies were conducted in solid tumors and hairy cell leukemia as part of the SCRUM-Japan MONSTAR-SCREEN, GI-SCREEN and GOZILA studies, which are collaborative industry-academic cancer genome screening projects led by the National Cancer Center Japan. The MEBGEN™ BRAF 3 Kit is expected to support personalized medicine based on its ability to detect the presence or absence of BRAF gene mutations in rare tumors (solid tumors including histiocytosis and hairy cell leukemia) for which treatment options are limited.